AMP Challenges FDA’s LDT Rule, Advocates for CLIA Modernization
AMP filed a lawsuit against the FDA for its new rule regulating LDTs as medical devices, advocating instead for modernizing CLIA regulations.
Read MorePosted by Andy Lundin | Sep 4, 2024 | Compliance |
AMP filed a lawsuit against the FDA for its new rule regulating LDTs as medical devices, advocating instead for modernizing CLIA regulations.
Read MorePosted by Andy Lundin | Aug 16, 2024 | Colorectal |
Universal DX initiated a clinical trial for its colorectal cancer screening blood test with the goal of achieving FDA premarket approval.
Read MorePosted by Chris Wolski | Aug 15, 2024 | Education |
While workforce shortages in the lab continue, a long-term solution could be more, varied educational opportunities.
Read MorePosted by Andy Lundin | Aug 13, 2024 | Compliance |
Labguru completed the SOC 2 Type 2 examination, demonstrating a commitment to high standards of security, privacy, and confidentiality.
Read MorePosted by Andy Lundin | Aug 13, 2024 | Lab Management |
Sapio Sciences has partnered with CREO to enhance laboratory operations through an integrated, end-to-end lab informatics platform.
Read More